1. Animal model studies yield translational solutions for cochlear drug delivery.
- Author
-
Frisina RD, Budzevich M, Zhu X, Martinez GV, Walton JP, and Borkholder DA
- Subjects
- Animals, Cochlea pathology, Cochlea physiopathology, Hearing Loss pathology, Hearing Loss physiopathology, Labyrinth Diseases pathology, Labyrinth Diseases physiopathology, Models, Animal, Cochlea drug effects, Drug Delivery Systems, Hearing drug effects, Hearing Loss drug therapy, Labyrinth Diseases drug therapy, Pharmaceutical Preparations administration & dosage, Translational Research, Biomedical methods
- Abstract
The field of hearing and deafness research is about to enter an era where new cochlear drug delivery methodologies will become more innovative and plentiful. The present report provides a representative review of previous studies where efficacious results have been obtained with animal models, primarily rodents, for protection against acute hearing loss such as acoustic trauma due to noise overexposure, antibiotic use and cancer chemotherapies. These approaches were initiated using systemic injections or oral administrations of otoprotectants. Now, exciting new options for local drug delivery, which opens up the possibilities for utilization of novel otoprotective drugs or compounds that might not be suitable for systemic use, or might interfere with the efficacious actions of chemotherapeutic agents or antibiotics, are being developed. These include interesting use of nanoparticles (with or without magnetic field supplementation), hydrogels, cochlear micropumps, and new transtympanic injectable compounds, sometimes in combination with cochlear implants., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF